Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The study aims to compare the efficacy of Empagliflozin or Linagliptin as an alternative to
Metformin for treatment of non-diabetic patients with polycystic ovary syndrome (PCOS).